1Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol,2001; 21(7):1104
2Birkedal-Hansen H, Moore WG, Bodden MK,et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med, 1993;4(2):197
3Matsuyama Y, Takao S, Aikou T. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J Surg Oncol, 2002 ;80(2):105
4Chan CC, Menges M, Orzechowski HD, et al. Increased matrix metalloproteinase 2 concentration and transcript expression in advanced colorectal carcinomas. Int J Colorectal Dis, 2001;16(3):133
5Shiozawa J, Ito M, Nakayama T, et al. Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol, 2000 ;13(9):925
6Garbett EA, Reed MW, Brown NJ. Proteolysis in human breast and colorectal cancer. Br J Cancer,1999 ;81(2):287
7Forsyth PA, Wong H, Laing TD, et al. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer, 1999 ;79(11-12):1828
8Mitsiades N, Yu WH, Poulaki V, et al. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res, 2001;61(2):577
9Boulay A, Masson R, Chenard MP, et al. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. Cancer Res, 2001 ;61(5):2189
10Jiang BH, Rue E, Wang GL, et al. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem, 1996 ;271(30):17771
二级参考文献29
1Kaio E, Tanaka S, Kitadai Y, et al. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology, 2003,64: 61-73.
2Furudoi A, Tanaka S, Haruma K, et al. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology, 2002,62:157-166.
3Kuwai T,Kitadai Y,Tanaka S, et al. Expression of hypoxia-inducible factor-1 alpha is associated with tumor vascularization in huaman colorectal carcinoma. Int J Cancer,2003,105:176-181.
4Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res, 1999, 59:5830-5835.
5Takahashi Y, Kitadai Y, Bucana CD, et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res, 1995, 55: 3964-3968.
6Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol,1995, 147: 9-19.
7Jiang BH, Semenza GL, Bauer C, et al. Hypoxia-inducible factor-1 level vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol,1996, 271: C1172-C1180.
8Semenza GL. Regulation of mammalian O2 hemeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol,1999, 15:551-578.
9Zhong H, Agani F, Baccala AA, et al. Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer. Cancer Res,1998,58:5280-5284.
10Wang GL, Jiang BH, Semenza GL, et al.Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1.Biochem Biophys Res Commun, 1995,216:669-675.
